Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to Which non FDA (United States Food and Drug Administration) approved peptides, such as BPC 157 (Body Protection Compound 157) and TB 500 (Thymosin Beta 500), are likely legitimate for medical use under strict supervision? An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA moves toward easing restrictions on certain peptides BioPharma Dive BPC 157 and Healing Peptides: Hype or Hope? A Doctor's Comprehensive Perspective MSK Doctor Zaid Matti